EUCTR2015-001292-51-DE进行中（未招募）1 期
Follow-Up Study in Patients with Acromegaly Previously Participating in Chiasma Study CH-ACM-01
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 98
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Patients who received at least one dose of octreotide capsules during CH ACM-01;
- •2. Patients who did not re-initiate medical treatment for acromegaly within the two week follow-up period OR patients who have been responders (IGF-1 less than or equal to 1.3 × ULN and GH <2.5 ng/mL at the end of treatment in the CH-ACM-01 study) and re-initiated treatment within the two week follow-up period. (Note: A list of patients that meet the above inclusion criteria will be provided by the Sponsor); and
- •Patients are able to understand and sign written informed consent to participate in the study.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 75
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 23
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Follow-Up Study in Patients that Participated in the Chiasma Study CH-ACM-01AcromegalyMedDRA version: 20.0Level: PTClassification code 10000599Term: AcromegalySystem Organ Class: 10014698 - Endocrine disordersEUCTR2015-001292-51-PLChiasma, Inc.98
进行中（未招募）
不适用
Follow-Up Study in Patients that Participated in the Chiasma Study CH-ACM-01MedDRA version: 18.0Level: PTClassification code 10000599Term: AcromegalySystem Organ Class: 10014698 - Endocrine disordersAcromegalyEUCTR2015-001292-51-SIChiasma, Inc.98
进行中（未招募）
1 期
Follow-Up Study in Patients that Participated in the Chiasma Study CHACM-01AcromegalyEUCTR2015-001292-51-ITCHIASMA INC.87
进行中（未招募）
不适用
Follow-Up Study in Patients that Participated in the Chiasma Study CH-ACM-01MedDRA version: 17.1Level: PTClassification code 10000599Term: AcromegalySystem Organ Class: 10014698 - Endocrine disordersAcromegalyEUCTR2015-001292-51-HUChiasma, Inc.98
已完成
不适用
Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following SurgeryAcromegalyNCT00500227Ipsen55